Calcium Hasco (o smaku malinovim)

Leaflet attached to the packaging: patient information

CALCIUM HASCO

115.6 mg of calcium ions / 5 ml, syrup
Calcii glubionas anhydricus + Calcii lactobionas dihydricus

Raspberry-flavored syrup

You should carefully read the contents of the leaflet before using the medicine, as it contains important information for the patient.

This medicine should always be used exactly as described in this patient leaflet or according to the doctor's or pharmacist's instructions.

• You should keep this leaflet, so you can read it again if you need to.
• If you need advice or additional information, you should consult a pharmacist.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. See section 4.
• If there is no improvement or the patient feels worse, they should contact their doctor.

Table of contents of the leaflet

• 1. What is Calcium Hasco and what is it used for
• 2. Important information before using Calcium Hasco
• 3. How to use Calcium Hasco
• 4. Possible side effects
• 5. How to store Calcium Hasco
• 6. Package contents and other information

1. What is Calcium Hasco and what is it used for

Calcium Hasco is a medicine containing calcium salts. Calcium is a building component of the body and plays an important role in many physiological processes (maintaining proper blood clotting, muscle contractions, nerve conduction, and cell membrane function). Calcium also reduces the permeability of blood vessel walls, acting as an anti-edema agent. Calcium passes through the placenta and into breast milk in nursing women.

Indications for use:

• prevention and supplementation of calcium deficiency in the body, e.g., during pregnancy or breastfeeding,
• treatment of osteoporosis,
• supportive treatment of allergy symptoms.

2. Important information before using Calcium Hasco

When not to use Calcium Hasco

• if the patient is allergic to the active substances (calcium salts) or to any of the other ingredients of this medicine (listed in section 6);
• if the patient has elevated calcium levels in the blood (hypercalcemia, e.g., in patients with hyperparathyroidism, severe kidney failure, or vitamin D overdose);
• if the patient has increased calcium excretion in the urine (hypercalciuria);
• if the patient has severe kidney failure or kidney stones;
• if the patient has an atrioventricular block.

1/4

Warnings and precautions

Before starting to use Calcium Hasco, you should discuss it with your doctor or pharmacist. You should be particularly cautious when using Calcium Hasco:

• if the patient has kidney failure;
• if the patient is taking high doses of vitamin D.

Calcium Hasco and other medicines

You should tell your doctor or pharmacist about all the medicines you are taking or have recently taken, as well as any medicines you plan to take. High doses of calcium taken with certain heart medicines (digitalis glycosides or calcium channel blockers) can cause serious heart rhythm disorders. Calcium significantly reduces the absorption of certain antibiotics (tetracyclines and quinolones), levothyroxine, nitrofurantoin, bisphosphonates, chlorpromazine, penicillamine, blood thinners, and fluorine compounds. Therefore, it is recommended to leave a 3-hour interval between taking Calcium Hasco syrup and the mentioned medicines. Diuretics from the thiazide group reduce calcium excretion, and vitamin D increases calcium absorption.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before using this medicine.

Driving and using machines

The medicine does not affect the ability to drive or use machines.

Calcium Hasco contains sucrose, sodium benzoate (E 211), propylene glycol (E 1520), and sodium

Sucrose

The medicine contains 1.5 g of sucrose in each 5 ml of syrup. This should be taken into account in patients with diabetes. If you have previously been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine.
Sodium benzoate (E 211)
The medicine contains 10 mg of sodium benzoate in each 5 ml of syrup. Sodium benzoate may increase the risk of jaundice (yellowing of the skin and eyes) in newborns (up to 4 weeks of age).

Propylene glycol (E 1520)

The medicine contains approximately 2.43 mg of propylene glycol in each 5 ml of syrup. Before administering the medicine to a child under 4 weeks of age, you should consult your doctor or pharmacist, especially if the child is taking other medicines containing propylene glycol or alcohol.

Sodium

The medicine contains less than 1 mmol (23 mg) of sodium in 5 ml of syrup, which means the medicine is considered "sodium-free".

3. How to use Calcium Hasco

This medicine should always be used exactly as described in this patient leaflet or according to the doctor's or pharmacist's instructions. If you have any doubts, you should consult your doctor or pharmacist. The medicine is taken orally.
2/4
Adults: 15 ml 2 or 3 times a day.
Children: up to 6 years: 5 ml 2 or 3 times a day, from 6 to 12 years: 10 ml 2 or 3 times a day.
The medicine should be measured using the enclosed measuring cup.
If you feel that the effect of Calcium Hasco is too strong or too weak, you should consult your doctor or pharmacist.

Using a higher dose of Calcium Hasco than recommended

No cases of overdose with Calcium Hasco have been reported. If you have taken a higher dose of the medicine than recommended, you should immediately consult your doctor.

Missing a dose of Calcium Hasco

You should not take a double dose to make up for a missed dose.
If you have any further doubts about using this medicine, you should consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rare side effects(in 1 to 10 patients out of 10,000):

• gastrointestinal disorders (constipation, diarrhea),
• in patients with kidney function disorders, oral administration of high doses of calcium can lead to hypercalcemia, whose symptoms are: nausea, abdominal pain, bone pain, and muscle weakness.

Reporting side effects

If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C, 02-222 Warsaw
tel.: +48 22 49 21 301, fax: + 48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help gather more information on the safety of the medicine.

5. How to store Calcium Hasco

Store at a temperature below 25°C. Store in the original packaging.
The medicine should be stored out of sight and reach of children.
Shelf life after first opening – 6 months.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the specified month.
3/4
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Package contents and other information

What Calcium Hasco contains

• The active substances of the medicine are organic calcium salts (calcium glukonolaktobionat anhydrous and calcium laktobionat dihydrate) in an amount equivalent to 115.6 mg of calcium ions in 5 ml of syrup.
• The other ingredients (excipients) are: sucrose, sodium benzoate (E 211), citric acid monohydrate (E 330), raspberry flavor (contains propylene glycol (E 1520)), purified water.

What Calcium Hasco looks like and what the package contains

The medicine is a yellowish syrup.
One package of the medicine (a brown glass bottle) contains 150 ml of solution.
The bottle with the measuring cup is placed in a cardboard box.

Marketing authorization holder and manufacturer

“PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK” S.A.
51-131 Wrocław, ul. Żmigrodzka 242 E

Medicine information

tel.: (22) 742 00 22
e-mail: informacjaoleku@hasco-lek.pl

Date of last update of the leaflet:

4/4